| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |